Fresh Healthy Vending International, Inc. (OTCBB:VEND) Recovers On Investors’ Conference News

Fresh Healthy Vending International, Inc. (OTCBB:VEND) is still offering attraction, adding more than 10% to a price of $2.98 on dollar volumes of $874,000. Despite the takers of the cream, VEND seems to have the energy for more positive days, especially given the indications that a paper mailer invites new investors. There has been no new email since Promotion Stock Secrets mentioned VEND for free on November 19th. VEND1122.png

The spike on Thursday is relatively small, given the fact that VEND recently presented at an investors’ forum at the World Franchise Conference in Dubai. Such forums often make the day for penny stocks as they invite serious buying. Now, it’s a wait-and-see whether VEND will push above $3 again, and if the health-conscious trend is enough to support the ticker.ENIP1122.png

Investors’ forums for VEND are relatively inactive, as the initial hype wore out. And VEND is active since quite recently, with little public to cheer the stock on. The climb was sudden, just like Wednesday’s reversal.

A red flag for VEND are the large holdings of CEO Nick Yates, who held more than 62% of the shares when the company ran under its previous name and ticker, Green 4 Media Inc. (OTCBB:GEEM), a symbol that hardly saw active trading. Even after the split, the possibility that insider selling happens is high.

The financials for VEND show that the company is capable of taking up its promised business model and realizing healthy cash flows. Yet the stock price is still high enough that profit-taking may be tempting, to shave off another faction of the price. At the end of the week and ahead of a new short trading period, we will be tracking VEND to see if there is a noticeable paper mailer effect, and if the stock shows fatigue.

Endeavor IP, Inc. (OTCBB:ENIP) for now has a stronger downward momentum despite the promise and the robust climbing trend a few weeks ago. An OTCBB status also did not ensure a more stable stock movement.

Biozone Pharmaceuticals, Inc. (OTCBB:BZNE) was only bought up after a long slide, as a price below 45 cents was seen as a buying opportunity.

In the case of VEND, the ticker has shown it reacts well to PR and other noise, so if the company puts in effort, the relatively high stock price may be maintained. But VEND is still too recent among the most actively traded tickers, so it is best to avoid investing, unless you can also afford sudden, large cuts.

 

You may also like...